First Western Trust Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
First Western Trust Bank's BMY Position: Q2 2026 in Review
First Western Trust Bank reduced its Bristol-Myers Squibb (BMY) stake by 0.22% in Q2 2026, selling an estimated $4.13K and leaving 32,542 shares worth $1.88M. The position accounts for 0.09% of the portfolio, ranked #66.
First Western Trust Bank first reported a position in BMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.15M in Q1 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- First Western Trust Bank held 32,542 shares of Bristol-Myers Squibb worth $1.88M as of Q2 2026.
- First Western Trust Bank sold 72 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.13K.
- Bristol-Myers Squibb made up 0.09% of First Western Trust Bank's portfolio in Q2 2026, its #66 holding.
- First Western Trust Bank first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 18 quarters since.
- First Western Trust Bank's Bristol-Myers Squibb position peaked at $3.15M in Q1 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on First Western Trust Bank's 13F filing for Q2 2026, filed 29 Jul 2026.